Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 6—June 2011

CME ACTIVITY

Cefepime-Resistant Pseudomonas aeruginosa

Ehimare Akhabue, Marie Synnestvedt, Mark G. Weiner, Warren B. Bilker, and Ebbing LautenbachComments to Author 
Author affiliations: Author affiliation: University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Main Article

Table 3

Multivariable model of association between infection with cefepime-resistant Pseudomonas aeruginosa and death, Philadelphia, PA, USA, 2001–2006*

Variable Adjusted OR (95% CI) p value
Cefepime-resistant organism 1.28 (0.86–1.90) 0.232
Patient in ICU at time of culture 2.33 (1.75–3.10) <0.001
APR-DRG 11.29 (6.53–19.50) <0.001
Patient transfer from outside hospital 1.38 (1.05–1.81) 0.021
Length of hospital stay before culture 0.99 (0.98–1.00) 0.231

*OR, odds ratio; CI, confidence interval; ICU, intensive care unit; APR-DRG, all-patient refined-diagnosis–related group.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO